V007-6046 Screening compound: 4-[2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBONYL]-N-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-2-AMINE

V007-6046 Screening compound: 4-[2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBONYL]-N-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-2-AMINE
V007-6046 Screening compound: 4-[2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBONYL]-N-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-2-AMINE alternative view

Chemical Structure Depiction of ChemDiv screening compound V007-6046
4-[2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBONYL]-N-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-2-AMINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V007-6046

Molecular Formula

C20H21F3N4O2S (C20 H21 F3 N4 O2 S)

Compound Name

4-[2-(PYRROLIDINE-1-CARBONYL)PYRROLIDINE-1-CARBONYL]-N-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-2-AMINE

IUPAC name

n/a

SMILES

O=C(C(CCC1)N1C(c1csc(Nc2cc(C(F)(F)F)ccc2)n1)=O)N1CCCC1

InChI

InChI=1S/C20H21F3N4O2S/c21-20(22,23)13-5-3-6-14(11-13)24-19-25-15(12-30-19)17(28)27-10-4-7-16(27)18(29)26-8-1-2-9-26/h3,5-6,11-12,16H,1-2,4,7-10H2,(H,24,25)/t16-/m0/s1

InChI Key

ANCVBDOCIHHTIM-INIZCTEOSA-N

MDL Number (MFCD)

MFCD19790401

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.47

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.155

Distribution Coefficient, logD

4.155

Water Solubility, LogSw

-4.24

Polar Surface Area

52.920

Acid Dissociation Constant (pKa)

16.31

Base Dissociation Constant (pKb)

0.61

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.00

V007-6046 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with V007-6046 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V007-6046?
Check Price and Availability of V007-6046, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V007-6046 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V007-6046
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V007-6046
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V007-6046 available by request